These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28750735)

  • 1. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
    Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N
    Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.
    Waddell LB; Lemckert FA; Zheng XF; Tran J; Evesson FJ; Hawkes JM; Lek A; Street NE; Lin P; Clarke NF; Landstrom AP; Ackerman MJ; Weisleder N; Ma J; North KN; Cooper ST
    J Neuropathol Exp Neurol; 2011 Apr; 70(4):302-13. PubMed ID: 21412170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy.
    Ono H; Suzuki N; Kanno SI; Kawahara G; Izumi R; Takahashi T; Kitajima Y; Osana S; Nakamura N; Akiyama T; Ikeda K; Shijo T; Mitsuzawa S; Nagatomi R; Araki N; Yasui A; Warita H; Hayashi YK; Miyake K; Aoki M
    Mol Ther; 2020 Apr; 28(4):1133-1153. PubMed ID: 32087766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
    Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction promoted by a dysferlin mutation.
    Fernández G; Arias-Bravo G; Bevilacqua JA; Castillo-Ruiz M; Caviedes P; Sáez JC; Cea LA
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165800. PubMed ID: 32305450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
    Vallecillo-Zúniga ML; Rathgeber MF; Poulson PD; Hayes S; Luddington JS; Gill HN; Teynor M; Kartchner BC; Valdoz J; Stowell C; Markham AR; Arthur C; Stowell S; Van Ry PM
    PLoS One; 2020; 15(9):e0238441. PubMed ID: 32881965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle Cells Fix Breaches by Orchestrating a Membrane Repair Ballet.
    Barthélémy F; Defour A; Lévy N; Krahn M; Bartoli M
    J Neuromuscul Dis; 2018; 5(1):21-28. PubMed ID: 29480214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.
    Sreetama SC; Chandra G; Van der Meulen JH; Ahmad MM; Suzuki P; Bhuvanendran S; Nagaraju K; Hoffman EP; Jaiswal JK
    Mol Ther; 2018 Sep; 26(9):2231-2242. PubMed ID: 30166241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice.
    Barzilai-Tutsch H; Dewulf M; Lamaze C; Butler Browne G; Pines M; Halevy O
    Hum Mol Genet; 2018 Aug; 27(16):2817-2829. PubMed ID: 29771357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcolemma wounding activates dynamin-dependent endocytosis in striated muscle.
    McDade JR; Naylor MT; Michele DE
    FEBS J; 2021 Jan; 288(1):160-174. PubMed ID: 32893434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Sarcolemmal Membrane Repair Exacerbates Striated Muscle Pathology in a Mouse Model of Duchenne Muscular Dystrophy.
    Paleo BJ; McElhanon KE; Bulgart HR; Banford KK; Beck EX; Sattler KM; Goines BN; Ratcliff SL; Crowe KE; Weisleder N
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
    Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
    PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy.
    Khodabukus A; Prabhu NK; Roberts T; Buldo M; Detwiler A; Fralish ZD; Kondash ME; Truskey GA; Koves TR; Bursac N
    Adv Sci (Weinh); 2024 Aug; 11(31):e2400188. PubMed ID: 38887849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane.
    Kerr JP; Ziman AP; Mueller AL; Muriel JM; Kleinhans-Welte E; Gumerson JD; Vogel SS; Ward CW; Roche JA; Bloch RJ
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20831-6. PubMed ID: 24302765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.
    Sellers SL; Milad N; White Z; Pascoe C; Chan R; Payne GW; Seow C; Rossi F; Seidman MA; Bernatchez P
    J Lipid Res; 2018 Feb; 59(2):261-272. PubMed ID: 29175948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem improves contractile properties of skeletal muscle in dysferlin-deficient BLAJ mice, but does not reduce contraction-induced muscle damage.
    Begam M; Collier AF; Mueller AL; Roche R; Galen SS; Roche JA
    Physiol Rep; 2018 Jun; 6(11):e13727. PubMed ID: 29890050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of Hemichannels Normalizes the Differentiation Fate of Myoblasts and Features of Skeletal Muscles from Dysferlin-Deficient Mice.
    Cea LA; Fernández G; Arias-Bravo G; Castillo-Ruiz M; Escamilla R; Brañes MC; Sáez JC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygous DYSF variants causing limb-girdle muscular dystrophy type 2B in a Chinese family.
    Li L; Jing Z; Cheng L; Liu W; Wang H; Xu Y; Zheng X; Yu X; Liu S
    J Gene Med; 2020 Nov; 22(11):e3272. PubMed ID: 32889728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.